Answer
Jinarc (tolvaptan) may reduce desmopressin’s effect in preventing or controlling bleeding by blocking vascular vasopressin V2 receptors involved in coagulation-factor release, so administering them together is not recommended.
Sources for this answer
- Jinarc 15mg TabletsOtsuka Pharmaceuticals (UK) Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 17Document updated
Sources checked